Physician
Procare Medical Group LLC
Procare Medical Group LLC was paid $2.94M by Medicaid between Jan 2018 and Jul 2023, across 70 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 59% of everything it billed.
33Billing provider infoPROCARE MEDICAL GROUP LLC
LAS VEGAS, NV 89118
LAS VEGAS, NV 89118
33aNPI1366618019assigned 05/02/2008
33bProvider typeFamily Medicine Physician
28Total paid$2.94M
24GClaims166,530
24DCodes billed70
24AFirst – last monthJan 2018 – Jul 2023
Compared with peers
Next to other Family Medicine Physician providers in Nevada
Rank by total paid#11 of 388
Median peer was paid$27K
This provider vs. median111×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,156 | $120K | |
| 2019 | 43,404 | $803K | |
| 2020 | 42,001 | $683K | |
| 2021 | 41,934 | $729K | |
| 2022 | 32,633 | $592K | |
| 2023 | 1,402 | $11K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 59% | 37,252 | 32,634 | $1.72M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 15% | 6,501 | 5,636 | $437K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 5.2% | 2,793 | 2,646 | $153K |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 4.1% | 1,213 | 1,165 | $120K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 4.0% | 6,451 | 4,736 | $119K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 4.0% | 1,604 | 1,501 | $116K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 2.3% | 1,400 | 1,298 | $68K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.5% | 1,393 | 1,287 | $44K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 4,162 | 1,820 | $34K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,306 | 1,054 | $19K |
| 93000 | <1% | 1,607 | 1,475 | $17K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,538 | 1,400 | $13K |
58 more codes
| 81003 | <1% | 8,060 | $11K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 469 | $8K |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 2,158 | $7K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 40 | $6K |
| 99439 | <1% | 351 | $5K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 310 | $5K |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | <1% | 160 | $5K |
| 81025 | <1% | 1,021 | $4K | |
| J1000 | Injection, depo-estradiol cypionate, up to 5 mg | <1% | 256 | $4K |
| 99490 | Ccm add 20min | <1% | 421 | $4K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 43 | $3K |
| 90658 | <1% | 293 | $2K | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 160 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 162 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 174 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 351 | $1K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 109 | $903.79 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 14 | $743.25 |
| 82962 | <1% | 466 | $644.68 | |
| 90682 | <1% | 18 | $543.18 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 468 | $450.25 |
| 94010 | <1% | 16 | $427.06 | |
| 90461 | <1% | 39 | $421.17 | |
| 99489 | Ccm add 20min | <1% | 16 | $351.87 |
| 99487 | Ccm add 20min | <1% | 16 | $339.02 |
| 96127 | <1% | 131 | $318.12 | |
| 94667 | <1% | 13 | $236.58 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 26 | $149.26 |
| 94664 | <1% | 14 | $137.33 | |
| 3079F | <1% | 18,004 | $107.38 | |
| 3074F | <1% | 31,665 | $68.62 | |
| 3077F | <1% | 2,814 | $47.47 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 14 | $31.14 |
| J7612 | Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg | <1% | 14 | $14.68 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 14 | $12.18 |
| A7004 | Small volume nonfiltered pneumatic nebulizer, disposable | <1% | 14 | $6.48 |
| 3078F | 0% | 19,227 | $0.00 | |
| 4040F | 0% | 216 | $0.00 | |
| G9744 | Patient not eligible due to active diagnosis of hypertension | 0% | 535 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 759 | $0.00 |
| G8752 | Most recent systolic blood pressure < 140 mmhg | 0% | 76 | $0.00 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 15 | $0.00 |
| 99072 | 0% | 570 | $0.00 | |
| 99401 | 0% | 23 | $0.00 | |
| 99173 | 0% | 103 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 146 | $0.00 |
| 90662 | 0% | 28 | $0.00 | |
| 90734 | 0% | 16 | $0.00 | |
| 3080F | 0% | 2,828 | $0.00 | |
| G9903 | Patient screened for tobacco use and identified as a tobacco non-user | 0% | 518 | $0.00 |
| 1036F | 0% | 682 | $0.00 | |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | 0% | 166 | $0.00 |
| 3075F | 0% | 4,657 | $0.00 | |
| 1101F | 0% | 131 | $0.00 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 65 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 110 | $0.00 |
| G8734 | Elder maltreatment screen documented as negative, follow-up is not required | 0% | 99 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGANTZ, AMBER (PRACTICE ADMINISTRATOR)